WE ARE...
Eliminating cold chain requirements
Our novel platforms enable temperature stable products that can be transported and stored at ambient temperatures.
AAHI's scientists apply a creative and pragmatic approach to protecting the world from disease, working to use our platform technologies to bring life-changing products to those who most need them.
WE ARE...
Our novel platforms enable temperature stable products that can be transported and stored at ambient temperatures.
Our immune-enhancing platforms use standard emulsion manufacturing technology and innovative and efficient manufacturing techniques that can be transferred to enable local production in low-and-middle income countries around the world.
Our adjuvant formulations and/or NLC can be made and stockpiled in readiness for combination with antigens or saRNA targeted to emerging threats.Our adjuvant formulations and/or NLC can be made and stockpiled in readiness for combination with antigens or saRNA targeted to emerging threats.
Our research demonstrates that intranasal administration of vaccines based on our platforms delivers strong mucosal immune responses, enhancing protection from respiratory diseases and potentially eliminating the need for needles.
Our scientists are exploring ways in which we can reduce the burden on our ecosystem and precious natural resources by sourcing environmentally sustainable raw vaccine materials and developing ever more efficient ways in which to use those materials.